Numab Therapeutics AG

Multi-specific antibodies that enable the pursuit of novel therapeutic strategies.

General Information
Company Name
Numab Therapeutics AG
Founded Year
2011
Location (Offices)
Horgen, Switzerland +1
Founders / Decision Makers
Number of Employees
68
Industries
Biopharma, Biotechnology, Health Care +2
Funding Stage
Series C
Social Media

Numab Therapeutics AG - Company Profile

Numab Therapeutics AG is a Swiss-based biopharmaceutical company founded in 2011. The company specializes in developing multi-specific antibody-based immunotherapies for inflammation and cancer. With a proprietary platform called λ-Cap™ and MATCH™, Numab has a unique advantage in overcoming historical drug discovery barriers. Their lead candidate, NM26, targets IL-4/13 and IL-31 for best-in-class efficacy in treating atopic dermatitis and other potential indications. The company recently received a Series C investment on December 5, 2022, with HBM Healthcare Investments participating as the investor. Numab's focus on innovative therapeutic strategies and its strong investor backing positions it as a key player in the biopharma and biotechnology sectors, with potential to deliver significant patient benefits.

Taxonomy: multi-specific antibodies, therapeutic strategies, immunotherapies, inflammation, cancer, drug discovery, pipeline, precision medicine, atopic dermatitis, therapeutic design, patient benefits, innovation, biopharmaceuticals

Funding Rounds & Investors of Numab Therapeutics AG (3)

View All
Funding Stage Amount No. Investors Investors Date
Series C Unknown 1 05 Dec 2022
Series C Fr.100.00M 9 Biotechnology Value Fund 19 May 2021
Series B Fr.22.00M - 12 Dec 2019

Latest News of Numab Therapeutics AG

View All

No recent news or press coverage available for Numab Therapeutics AG.

Similar Companies to Numab Therapeutics AG

View All
ExeVir - Similar company to Numab Therapeutics AG
ExeVir Rapid Viral control in a world that needs it
EpiBiologics - Similar company to Numab Therapeutics AG
EpiBiologics Next Generation Protein Degradation
Enlaza Therapeutics - Similar company to Numab Therapeutics AG
Enlaza Therapeutics Pioneering Covalent Biologics
Mabqi - Similar company to Numab Therapeutics AG
Mabqi Your key partner for breakthrough antibody discovery
Spyre Therapeutics - Similar company to Numab Therapeutics AG
Spyre Therapeutics Engineering for new heights in the treatment of inflammatory bowel disease